FDA 483 - DiFusion Technologies - February 12, 2026

An FDA inspection of DiFusion Technologies in Austin, TX, from February 9-12, 2026, revealed a significant quality system deficiency. The firm failed to conduct internal audits at planned intervals, as required by its own procedures. This indicates a lapse in ensuring the Quality Management System is effectively implemented and maintained.